title: A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles.
abstract: Silver is a strong antibiotic that is increasingly incorporated into consumer products as a bulk, salt, or nanosilver, thus potentially causing side-effects related to human exposure. However, the fate and behavior of (nano)silver in the human body is presently not well understood. In order to aggregate the existing experimental information, a physiologically based pharmacokinetic model (PBPK) was developed in this study for ionic silver and nanosilver. The structure of the model was established on the basis of toxicokinetic data from intravenous studies. The number of calibrated parameters was minimized in order to enhance the predictive capability of the model. We validated the model structure for both silver forms by reproducing exposure conditions (dermal, oral, and inhalation) of in vivo experiments and comparing simulated and experimentally assessed organ concentrations. Therefore, the percutaneous, intestinal, or pulmonary absorption fraction was estimated based on the blood silver concentration of the respective experimental data set. In all of the cases examined, the model could successfully predict the biodistribution of ionic silver and 15-150 nm silver nanoparticles, which were not coated with substances designed to prolong the circulatory time (eg, polyethylene glycol). Furthermore, the results of our model indicate that: (1) within the application domain of our model, the particle size and coating had a minor influence on the biodistribution; (2) in vivo, it is more likely that silver nanoparticles are directly stored as insoluble salt particles than dissolve into Ag⁺; and (3) compartments of the mononuclear phagocytic system play a minor role in exposure levels that are relevant for human consumers. We also give an example of how the model can be used in exposure and risk assessments based on five different exposure scenarios, namely dietary intake, use of three separate consumer products, and occupational exposure.
authors.affiliation: ETH Zurich, Institute for Chemical and Bioengineering, Zurich, Switzerland.
authors.forename: Gerald
authors.initials: G
authors.lastname: Bachler
authors.forename: Natalie
authors.initials: N
authors.lastname: von Goetz
authors.forename: Konrad
authors.initials: K
authors.lastname: Hungerbühler
mesh_terms: D000818:Animals; D003198:Computer Simulation; D006801:Humans; D007477:Ions / Q000493:pharmacokinetics*; D008657:Metabolic Clearance Rate; D053768:Metal Nanoparticles / Q000737:chemistry*; D008954:Models, Biological; D009928:Organ Specificity / Q000502:physiology*; D010587:Phagocytosis / Q000502:physiology*; D051381:Rats; D012834:Silver / Q000737:chemistry* / Q000493:pharmacokinetics*; D013045:Species Specificity; D014018:Tissue Distribution
chemical_list: D007477:Ions; D012834:Silver
keywords: PBPK model; biodistribution; human exposure; nanosilver; risk assessment; toxicokinetics
references.citation: Inhal Toxicol. 2009 Nov;21(13):1099-107
references.pmid: 19814607
references.citation: Ann ICRP. 2002;32(3-4):5-265
references.pmid: 14506981
references.citation: J Angiogenes Res. 2010 Aug 11;2:14
references.pmid: 20701757
references.citation: Environ Sci Technol. 2012 Jul 3;46(13):6900-14
references.pmid: 22339502
references.citation: Toxicol Lett. 2007 Jan 30;168(2):176-85
references.pmid: 17197136
references.citation: Toxicol Appl Pharmacol. 1979 Aug;50(1):49-55
references.pmid: 494300
references.citation: Arch Pharm Res. 2011 Jan;34(1):153-8
references.pmid: 21468927
references.citation: Dermatol Online J. 2005 Mar 01;11(1):12
references.pmid: 15748553
references.citation: Small. 2010 Aug 2;6(15):1669-78
references.pmid: 20602428
references.citation: Nanotoxicology. 2012 Sep;6(6):667-9
references.pmid: 21777050
references.citation: Environ Health Perspect. 2001 Aug;109 Suppl 4:547-51
references.pmid: 11544161
references.citation: J Pineal Res. 2007 Jan;42(1):28-42
references.pmid: 17198536
references.citation: Cornea. 1992 May;11(3):264-9
references.pmid: 1587137
references.citation: J Burn Care Rehabil. 1999 May-Jun;20(3):195-200
references.pmid: 10342470
references.citation: Exp Physiol. 1997 Mar;82(2):291-5
references.pmid: 9129943
references.citation: Arch Surg. 1968 Feb;96(2):184-8
references.pmid: 5638080
references.citation: Toxicol Lett. 2008 Jan 4;176(1):1-12
references.pmid: 18022772
references.citation: J Appl Toxicol. 2012 Nov;32(11):890-9
references.pmid: 22522906
references.citation: Toxicology. 1981;21(3):179-86
references.pmid: 7292506
references.citation: Inhal Toxicol. 2009 Jul;21 Suppl 1:55-60
references.pmid: 19558234
references.citation: Spectrochim Acta A Mol Biomol Spectrosc. 2007 Feb;66(2):364-70
references.pmid: 16843708
references.citation: J Drug Target. 2005 Apr;13(3):179-87
references.pmid: 16036306
references.citation: Histol Histopathol. 2011 Jun;26(6):689-97
references.pmid: 21472684
references.citation: Nanotoxicology. 2013 Nov;7(7):1198-210
references.pmid: 22931191
references.citation: Nanotoxicology. 2010 Sep;4(3):284-95
references.pmid: 20795910
references.citation: Environ Sci Technol. 2011 Jun 15;45(12):5260-6
references.pmid: 21598969
references.citation: Histol Histopathol. 2009 Feb;24(2):167-73
references.pmid: 19085833
references.citation: Environ Sci Technol. 2013 Sep 3;47(17):9979-87
references.pmid: 23786648
references.citation: Am J Pathol. 1927 Nov;3(6):631-652.15
references.pmid: 19969770
references.citation: Health Phys. 1968 Dec;15(6):505-14
references.pmid: 4972147
references.citation: Environ Health Perspect. 2010 Mar;118(3):407-13
references.pmid: 20064793
references.citation: Eur J Pharm Biopharm. 2011 Apr;77(3):407-16
references.pmid: 21195759
references.citation: J Occup Health. 2008;50(6):521-4
references.pmid: 18971576
references.citation: Fundam Appl Toxicol. 1985 Oct;5(5):816-31
references.pmid: 4065458
references.citation: Arch Toxicol. 2012 Jul;86(7):1021-60
references.pmid: 22576463
references.citation: Arch Toxicol. 2011 Jul;85(7):743-50
references.pmid: 20428844
references.citation: Int Arch Occup Environ Health. 1985;56(3):207-15
references.pmid: 4066049
references.citation: Histochemistry. 1981;71(2):177-86
references.pmid: 7239944
references.citation: J Cutan Pathol. 2009 Jul;36(7):788-92
references.pmid: 19519610
references.citation: Pharm Res. 2008 Aug;25(8):1815-21
references.pmid: 18373181
references.citation: J Cutan Pathol. 2006 Dec;33(12):809-11
references.pmid: 17177941
references.citation: ACS Nano. 2010 Nov 23;4(11):6903-13
references.pmid: 20968290
references.citation: Nanotoxicology. 2011 Jun;5(2):140-56
references.pmid: 21609136
references.citation: Nano Lett. 2009 Feb;9(2):794-9
references.pmid: 19128005
references.citation: ACS Nano. 2011 May 24;5(5):4091-103
references.pmid: 21480625
references.citation: Biochem J. 2004 Jan 1;377(Pt 1):159-69
references.pmid: 14505488
references.citation: Int J Nanomedicine. 2012;7:1345-56
references.pmid: 22419876
references.citation: Plast Reconstr Surg. 1966 Jun;37(6):550-1
references.pmid: 5932415
references.citation: J Invest Dermatol. 2006 Jun;126(6):1316-22
references.pmid: 16614727
references.citation: Environ Toxicol Pharmacol. 2010 Sep;30(2):162-8
references.pmid: 21787647
references.citation: Toxicol Lett. 2009 Oct 28;190(2):156-62
references.pmid: 19607894
references.citation: Inhal Toxicol. 2007 Aug;19(10):857-71
references.pmid: 17687717
references.citation: Small. 2008 Dec;4(12):2108-11
references.pmid: 19031432
references.citation: Environ Sci Technol. 2011 Sep 1;45(17):7345-53
references.pmid: 21770469
references.citation: Ann ICRP. 1994;24(1-3):1-482
references.pmid: 7726471
references.citation: Sci Total Environ. 1992 Jun 9;120(1-2):93-6
references.pmid: 1641644
references.citation: Bull World Health Organ. 1972;46(6):845-52
references.pmid: 4538544
references.citation: Life Sci. 1987 Apr 20;40(16):1553-60
references.pmid: 3561165
references.citation: Trends Biotechnol. 2010 Nov;28(11):580-8
references.pmid: 20724010
references.citation: Inhal Toxicol. 2008 Apr;20(6):567-74
references.pmid: 18444009
references.citation: Part Fibre Toxicol. 2011 Jun 01;8:18
references.pmid: 21631937
references.citation: Toxicol Lett. 2011 Feb 25;201(1):27-33
references.pmid: 21145381
references.citation: Biomaterials. 2010 Nov;31(32):8350-61
references.pmid: 20684985
references.citation: J Magn Reson Imaging. 1999 May;9(5):643-52
references.pmid: 10331759
references.citation: J Toxicol Environ Health A. 2009;72(21-22):1279-84
references.pmid: 20077197
references.citation: Neurotoxicology. 2012 Jun;33(3):416-23
references.pmid: 22531227
references.citation: Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):422-7
references.pmid: 19122143
references.citation: Environ Sci Technol. 2011 Dec 15;45(24):10713-9
references.pmid: 22070550
references.citation: PLoS One. 2010 Apr 06;5(4):e10051
references.pmid: 20386614
references.citation: Toxicology. 2006 May 15;222(3):195-201
references.pmid: 16584826
references.citation: ACS Nano. 2012 Aug 28;6(8):7427-42
references.pmid: 22857815
references.citation: J Nanosci Nanotechnol. 2004 May;4(5):484-8
references.pmid: 15503433
references.citation: Inhal Toxicol. 2008 Apr;20(6):575-83
references.pmid: 18444010
references.citation: J Control Release. 2001 Apr 2;71(2):203-11
references.pmid: 11274752
references.citation: Chemosphere. 2012 Oct;89(7):817-24
references.pmid: 22677521
references.citation: J Appl Toxicol. 2012 Nov;32(11):920-8
references.pmid: 22696427
references.citation: Australas J Dermatol. 1996 Nov;37(4):185-7
references.pmid: 8961584
references.citation: Ann Occup Hyg. 2005 Oct;49(7):575-85
references.pmid: 15964881
references.citation: Clin Exp Dermatol. 1980 Sep;5(3):305-11
references.pmid: 7438526
references.citation: Nat Biotechnol. 2007 Oct;25(10):1165-70
references.pmid: 17891134
references.citation: Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2013;30(3):612-20
references.pmid: 23406534
references.citation: Langenbecks Arch Surg. 2009 May;394(3):495-502
references.pmid: 19280220
references.citation: Metallomics. 2010 Mar;2(3):204-10
references.pmid: 21069158